PROGNOSTIC FACTORS FOR ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA FOLLOWING TREATMENT WITH COMBINATION CHEMOTHERAPY

被引：218
|
作者：
FISHER, RI [1 ]
DEVITA, VT [1 ]
JOHNSON, BL [1 ]
SIMON, R [1 ]
YOUNG, RC [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,MED BRANCH,BETHESDA,MD 20014
来源：
AMERICAN JOURNAL OF MEDICINE | 1977年 / 63卷 / 02期
关键词：
D O I：
10.1016/0002-9343(77)90230-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：177 / 182
页数：6
相关论文
共 50 条
  • [21] LONG-TERM REMISSION IN DIFFUSE HISTIOCYTIC LYMPHOMA TREATED WITH COMBINATION SEQUENTIAL CHEMOTHERAPY
    BERD, D
    CORNOG, J
    DECONTI, RC
    LEVITT, M
    BERTINO, JR
    [J]. CANCER, 1975, 35 (04) : 1050 - 1054
  • [22] PROGNOSTIC FACTORS AFFECTING THE CURABILITY OF DIFFUSE MIXED (DML), DIFFUSE HISTIOCYTIC (DHL), AND DIFFUSE UNDIFFERENTIATED LYMPHOMA (DUL)
    FISHER, RI
    HUBBARD, SM
    DEVITA, VT
    BERARD, C
    WESLEY, R
    COSSMAN, J
    LEWIS, BJ
    YOUNG, RC
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 162 - 162
  • [23] COMBINATION THERAPY FOR DIFFUSE HISTIOCYTIC LYMPHOMA THAT INCLUDES ANTIMETABOLITES
    CADMAN, E
    FARBER, L
    BERD, D
    BERTINO, J
    [J]. CANCER TREATMENT REPORTS, 1977, 61 (06): : 1109 - 1116
  • [24] MULTIPLE AGENT CHEMOTHERAPY FOR ADVANCED HISTIOCYTIC LYMPHOMA
    ADLER, S
    SHIMAOKA, K
    HAN, T
    TSUKADA, Y
    [J]. EUROPEAN JOURNAL OF CANCER, 1976, 12 (05) : 395 - 403
  • [25] PREDICTIVE MODEL FOR PROGNOSIS IN ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA
    DANIEU, L
    WONG, G
    KOZINER, B
    CLARKSON, B
    [J]. CANCER RESEARCH, 1986, 46 (10) : 5372 - 5379
  • [26] DIFFUSE LARGE CELL LYMPHOMA - PROGNOSTIC FACTORS WITH TREATMENT
    STRAUS, DJ
    WONG, G
    YAHALOM, J
    VARSOS, G
    GULATI, S
    CLARKSON, B
    [J]. LEUKEMIA, 1991, 5 : 32 - 37
  • [27] COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED MEDITERRANEAN ABDOMINAL LYMPHOMA
    SALEM, P
    MOURADIAN, S
    BADRAN, G
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 317 - 317
  • [28] RELAPSE WITH NODULAR LYMPHOMA FOLLOWING COMBINATION CHEMOTHERAPY FOR DIFFUSE NON-HODGKINS-LYMPHOMA
    SIEGEL, RD
    SKARIN, AT
    CANELLOS, GP
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (05): : 420 - 423
  • [29] PROGNOSTIC INDICATORS IN DIFFUSE LARGE-CELL (HISTIOCYTIC) LYMPHOMA
    TODD, MB
    PORTLOCK, CS
    FARBER, LR
    HOLFORD, TR
    BERTINO, JR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (04): : 593 - 601
  • [30] TRANSFORMED DIFFUSE HISTIOCYTIC LYMPHOMA (TRDHL) - A POOR PROGNOSTIC VARIANT
    ARMITAGE, JO
    DICK, FR
    CORDER, MP
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 182 - 182
12345